These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 762416

  • 1. Characterization of an antiserum specific for the Fabalpha fragment. Its use for detection of alpha-heavy chain disease protein by immunoselection.
    Doe WF, Spiegelberg HL.
    J Immunol; 1979 Jan; 122(1):19-23. PubMed ID: 762416
    [Abstract] [Full Text] [Related]

  • 2. Immunodiagnosis of alpha chain disease.
    Doe WF, Danon F, Seligmann M.
    Clin Exp Immunol; 1979 May; 36(2):189-97. PubMed ID: 113152
    [Abstract] [Full Text] [Related]

  • 3. A comparison of several immunochemical approaches for the screening of alpha chain disease.
    Orr KB.
    Diagn Immunol; 1983 May; 1(1):43-8. PubMed ID: 6437724
    [Abstract] [Full Text] [Related]

  • 4. Differential susceptibility of human IgA immunoglobulins to streptococcal IgA protease.
    Plaut AG, Wistar R, Capra JD.
    J Clin Invest; 1974 Dec; 54(6):1295-300. PubMed ID: 4436434
    [Abstract] [Full Text] [Related]

  • 5. Spontaneous enzymatic cleavage of IgD myeloma protein giving a pattern of delta heavy chain disease.
    Rabhi H, Ghaffor M, Abbadi MC.
    Arch Inst Pasteur Alger; 1989 Dec; 57():135-40. PubMed ID: 2518742
    [Abstract] [Full Text] [Related]

  • 6. Human myeloma IgA half-molecules.
    Spiegelberg HL, Fishkin BG.
    J Clin Invest; 1976 Nov; 58(5):1259-65. PubMed ID: 993344
    [Abstract] [Full Text] [Related]

  • 7. Normal human sera contain antibodies directed at Fab of IgA.
    Jackson S, Montgomery RI, Mestecky J, Czerkinsky C.
    J Immunol; 1987 Apr 01; 138(7):2244-8. PubMed ID: 3494062
    [Abstract] [Full Text] [Related]

  • 8. Production and characterization of pepsin fragments of human IgA1 to determine domain-specificity of monoclonal anti-IgA antibodies.
    Biewenga J, Faber A, Pronk JC, Haaijman JJ.
    Immunology; 1986 Sep 01; 59(1):153-8. PubMed ID: 3093370
    [Abstract] [Full Text] [Related]

  • 9. IgA1 half molecules in human multiple myeloma and the in vitro production of similar fragments from intact IgA1 molecules.
    Biewenga J, Van Loghem E.
    Clin Exp Immunol; 1983 Feb 01; 51(2):395-400. PubMed ID: 6839548
    [Abstract] [Full Text] [Related]

  • 10. Distribution and association of heavy and light chain variable region subgroups among human IgA immunoglobulins.
    Capra JD, Kehoe JM.
    J Immunol; 1975 Feb 01; 114(2 Pt 1):678-81. PubMed ID: 804511
    [Abstract] [Full Text] [Related]

  • 11. Studies on fd fragments of human immunoglobulins. III. Immunogenic properties of gamma chains, myeloma fd gamma, and myeloma fd1 alpha.
    Zegers JM, Ballieux RE, van Loghem E.
    Scand J Immunol; 1975 Feb 01; 4(2):161-9. PubMed ID: 806961
    [Abstract] [Full Text] [Related]

  • 12. [Monoclonal IgA serum protein having a poor precipitation reaction to anti-lambda chain antiserum in the patient with multiple myeloma].
    Sato K, Michibayashi T.
    Rinsho Byori; 1985 Dec 01; 33(12):1425-9. PubMed ID: 3938490
    [No Abstract] [Full Text] [Related]

  • 13. Similarities of the light chains and the variable regions of the heavy chains of the IgG2 lambda and IgA1 lambda myeloma proteins from a single patient.
    Wolfenstein-Todel C, Franklin EC, Rudders RA.
    J Immunol; 1974 Mar 01; 112(3):871-6. PubMed ID: 4811968
    [No Abstract] [Full Text] [Related]

  • 14. [Isolation of antisera to different IgA determinants and an analysis of the antigenic structure of human monoclonal IgA].
    German GP.
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jun 01; (6):52-8. PubMed ID: 2412371
    [Abstract] [Full Text] [Related]

  • 15. Determination of the light chain type of paraproteins, identification of heavy chain disease.
    Backhausz R, Lajos J.
    Ann Immunol Hung; 1972 Jun 01; 16(0):43-50. PubMed ID: 4213025
    [No Abstract] [Full Text] [Related]

  • 16. The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling.
    Boehm MK, Woof JM, Kerr MA, Perkins SJ.
    J Mol Biol; 1999 Mar 12; 286(5):1421-47. PubMed ID: 10064707
    [Abstract] [Full Text] [Related]

  • 17. Primary structure of a human IgA1 immunoglobulin. IV. Streptococcal IgA1 protease, digestion, Fab and Fc fragments, and the complete amino acid sequence of the alpha 1 heavy chain.
    Putnam FW, Liu YS, Low TL.
    J Biol Chem; 1979 Apr 25; 254(8):2865-74. PubMed ID: 107164
    [Abstract] [Full Text] [Related]

  • 18. Identification and some properties of rat secretory component.
    Vaerman JP, Heremans JF, Bazin H, Beckers A.
    J Immunol; 1975 Jan 25; 114(1 Pt 2):265-9. PubMed ID: 803998
    [Abstract] [Full Text] [Related]

  • 19. [IgG-lambda myeloma protein "nonreactive" with anti-IgG-Fab and anti-light chain antisera].
    Niiya K, Taguchi H, Yoshimoto S, Miyoshi I, Fujishita M, Yube T.
    Rinsho Ketsueki; 1983 May 25; 24(5):588-93. PubMed ID: 6411950
    [No Abstract] [Full Text] [Related]

  • 20. Actions of three clostridial IgA proteases on distinct forms of immunoglobulin A molecules.
    Hashim OH, Hassan H.
    Immunology; 1991 Jun 25; 73(2):235-8. PubMed ID: 2071167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.